Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001044351 | SCV001208142 | uncertain significance | Dilated cardiomyopathy 1W | 2025-01-20 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 823 of the VCL protein (p.Arg823Trp). This variant is present in population databases (rs779047174, gnomAD 0.003%). This missense change has been observed in individual(s) with cardiomyopathy (PMID: 30847666). ClinVar contains an entry for this variant (Variation ID: 202149). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002453669 | SCV002738243 | uncertain significance | Cardiovascular phenotype | 2024-07-21 | criteria provided, single submitter | clinical testing | The c.2467C>T (p.R823W) alteration is located in exon 17 (coding exon 17) of the VCL gene. This alteration results from a C to T substitution at nucleotide position 2467, causing the arginine (R) at amino acid position 823 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV001529152 | SCV003820363 | uncertain significance | not provided | 2021-05-12 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003486742 | SCV004240244 | uncertain significance | Cardiomyopathy | 2022-07-04 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004800321 | SCV005422634 | uncertain significance | not specified | 2024-10-21 | criteria provided, single submitter | clinical testing | Variant summary: VCL c.2467C>T (p.Arg823Trp) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.2e-05 in 251458 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.2467C>T has been reported in the literature in one individual affected with unknown cardiomyopathy (van Lint FHM_2019). These report(s) do not provide unequivocal conclusions about association of the variant with Cardiomyopathy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 30847666). ClinVar contains an entry for this variant (Variation ID: 202149). Based on the evidence outlined above, the variant was classified as uncertain significance. |
Diagnostic Laboratory, |
RCV001529152 | SCV001742148 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV001529152 | SCV001925660 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001529152 | SCV001931273 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001529152 | SCV001952868 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001529152 | SCV001968686 | uncertain significance | not provided | no assertion criteria provided | clinical testing |